...
首页> 外文期刊>Gene Therapy and Molecular Biology >DNA methyltransferase: a downstream effector of oncogenic programs; implications for therapy.
【24h】

DNA methyltransferase: a downstream effector of oncogenic programs; implications for therapy.

机译:DNA甲基转移酶:致癌程序的下游效应子;对治疗的意义。

获取原文
           

摘要

DNA MeTase is an attractive anticancer target. A molecular analysis of its regulation suggests that it is a downstream effector of many oncogenic pathways and that its down modulation can inhibit tumor growth. It is possible that DNA MeTase inhibitor will be effective in a broad spectrum of cancers because it lies downstream to nodal cellular checkpoints that could be activated by multiple ways. An important challenge is to design novel inhibitors of DNA MeTase that are highly specific. Such inhibitors are potentially important pharmacological agents with wide therapeutic applications.
机译:DNA MeTase是一种有吸引力的抗癌靶标。对其调节的分子分析表明,它是许多致癌途径的下游效应子,并且其下调可以抑制肿瘤的生长。 DNA MeTase抑制剂可能在广泛的癌症中有效,因为它位于可通过多种方式激活的淋巴结细胞检查点的下游。一个重要的挑战是设计高度特异性的新型DNA MeTase抑制剂。这类抑制剂是潜在的重要药物,具有广泛的治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号